TARA FY 2020 Earnings — Protara Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TARAProtara Therapeutics, Inc.

$211M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$196,000

Operating Income

-$34M

Net Income

-$34M

EPS (Diluted)

$-4.70

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$24M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$203M

Total Liabilities

$4M

Stockholders' Equity

$199M

Cash & Equivalents

$169M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$196,000	-$16,000	-1125.0%
Operating Income	-$34M	-$15M	-125.8%
Net Income	-$34M	-$15M	-126.6%